Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)

dc.contributor.authorSeyfoori, Amir
dc.contributor.authorShokrollahi Barough, Mahdieh
dc.contributor.authorMokarram, Pooneh
dc.contributor.authorAhmadi, Mazaher
dc.contributor.authorMehrbod, Parvaneh
dc.contributor.authorSheidary, Alireza
dc.contributor.authorMadrakian, Tayyebeh
dc.contributor.authorKiumarsi, Mohammad
dc.contributor.authorWalsh, Tavia
dc.contributor.authorMvAlinden, Kielan D.
dc.contributor.authorGhosh, Chandra C.
dc.contributor.authorSharma, Pawan
dc.contributor.authorZeki, Amir A.
dc.contributor.authorGhavami, Saeid
dc.contributor.authorAkbari, Mohsen
dc.date.accessioned2021-07-31T15:50:58Z
dc.date.available2021-07-31T15:50:58Z
dc.date.copyright2021en_US
dc.date.issued2021
dc.description.abstractViral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. For the past 100 years, viral associated respiratory epidemics have been the most common cause of infectious disease worldwide. Due to several drawbacks of the current anti-viral treatments, such as drug resistance generation and non-targeting of viral proteins, the development of novel nanotherapeutic or nano-vaccine strategies can be considered essential. Due to their specific physical and biological properties, nanoparticles hold promising opportunities for both anti-viral treatments and vaccines against viral infections. Besides the specific physiological properties of the respiratory system, there is a significant demand for utilizing nano-designs in the production of vaccines or antiviral agents for airway-localized administration. SARS-CoV-2, as an immediate example of respiratory viruses, is an enveloped, positive-sense, single-stranded RNA virus belonging to the coronaviridae family. COVID-19 can lead to acute respiratory distress syndrome, similarly to other members of the coronaviridae. Hence, reviewing the current and past emerging nanotechnology-based medications on similar respiratory viral diseases can identify pathways towards generating novel SARS-CoV-2 nanotherapeutics and/or nano-vaccines.en_US
dc.description.reviewstatusRevieweden_US
dc.description.scholarlevelFacultyen_US
dc.identifier.citationSeyfoori, A., Shokrollahi Barough, M., Mokarram, P., Ahmadi, M., Mehrbod, P., Sheidary, A., … Akbari, M. (2021). Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID). International Journal of Molecular Sciences, 22(13), 1-31. https://doi.org/10.3390/ijms22136937.en_US
dc.identifier.urihttps://doi.org/10.3390/ijms22136937
dc.identifier.urihttp://hdl.handle.net/1828/13198
dc.language.isoenen_US
dc.publisherInternational Journal of Molecular Sciencesen_US
dc.subjectviral infection
dc.subjectSARS-CoV-2
dc.subjectnanomedicine
dc.subjectrespiratory disease
dc.subjectnano-vaccine
dc.subjectCOVID-19
dc.subjectLaboratory for Innovations in Micro Engineering (LiME)
dc.subjectCentre for Advanced Materials and Related Technology (CAMTEC)
dc.subject.departmentDepartment of Mechanical Engineering
dc.titleEmerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)en_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Seyfoori_Amir_IntJMolSci_2021.pdf
Size:
2.86 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2 KB
Format:
Item-specific license agreed upon to submission
Description: